Yuhan-Kimberly, a joint venture between Korea’s Yuhan Corp. and America’s Kimberly Clark, has been chosen as one of the ...

Singer and actress IU is fighting against the haters. Among the malicious comments under criminal complaint, a person ...

SEOUL, Oct. 28 (Yonhap) -- Yuhan Corp., a South Korean biopharmaceutical company, said Monday its third-quarter net profit ...

Yuhan Corporation CEO Wook Je Cho, National Assembly Member Seong Hoon Park, and KAIST Professor Joung Ho Kim join a ...

Reporting in the journal Nature, Caltech-led researchers have uncovered where FRBs are more likely to occur in the ...

Gilead Sciences has abandoned a liver disease collaboration with Yuhan. A new study suggests Leqembi's vial design could cost Medicare hundreds of millions of dollars in waste each year.

The rising prevalence of urticaria is fueling market growth, with increased allergic responses and lifestyle shifts playing key roles. Advances in biologic treatments and a strong development pipeline ...

In terms of improving the wellbeing of all mankind, China and the US should give full play to their respective advantages and ...

In Pictures The denim fair Kingpins celebrated its tenth anniversary edition in Amsterdam last week. A highlight of the fair ...

Did you know that swapping a daily serving of processed red meat for a serving of nuts or legumes is linked to a 20% lower ...

Gilead Sciences Inc. terminated a potential $785 million licensing deal with Yuhan Corp. inked in 2019 to develop metabolic dysfunction-associated steatohepatitis (MASH) therapies. BioWorld Asia Deals ...